S‐1 vs 5‐FU‐containing regimens
Treatment discontinuation due to toxicity · people with advanced gastric cancer
S‐1 showed no clear difference in treatment discontinuation due to toxicity compared with 5‐FU‐containing regimens (high certainty).
1 finding from 1 review
- OR 0.85 [0.63, 1.13]3 studies · 1726 participantsHigh